Abstract
Nesfatin-1, a newly discovered satiety molecule which reduces feeding behavior, has been recognized as a unique regulatory neuropeptide with its multiple roles, both central and peripheral. However, whether it had neuronal modulation effect on dopaminergic neurons is largely unknown. In the present study, using whole-cell patch clamp under current-clamp mode, we investigate the effects of nesfatin-1 on the electrical activity of rat nigral dopaminergic neurons. Nesfatin-1 could produce a resting membrane potential hyperpolarization on the majority of dopaminergic neurons tested. The spike frequency decreased by 23.13 ± 5.93 and 43.20 ± 5.56 % in 5-nM and 10-nM nesfatin-1 groups, respectively. These effects persisted in the presence of ionotropic glutamate and GABA receptor antagonists. Our study suggests that nesfatin-1 postsynaptically inhibits the electrical activity of nigral dopaminergic neurons.
Similar content being viewed by others
References
Aydin S, Dag E, Ozkan Y et al (2009) Nesfatin-1 and ghrelin levels in serum and saliva of epileptic patients: hormonal changes can have a major effect on seizure disorders. Mol Cell Biochem 328(1–2):49–56
Bishop MW, Chakraborty S, Matthews GA et al (2010) Hyperexcitable substantia nigra dopamine neurons in PINK1- and HtrA2/Omi-deficient mice. J Neurophysiol 104(6):3009–3020
Brailoiu GC, Dun SL, Brailoiu E et al (2007) Nesfatin-1: distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 148(10):5088–5094
Chen X, Dong J, Jiang ZY (2012) Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake. Regul Pept 177(1–3):21–26
Cristina Brailoiu G, Deliu E, Tica AA et al (2013) Nesfatin-1 activates cardiac vagal neurons of nucleus ambiguus and elicits bradycardia in conscious rats. J Neurochem 126(6):739–748
Fannjiang Y, Kim CH, Huganir RL et al (2003) BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. Dev Cell 4(4):575–585
Foo KS, Brauner H, Ostenson CG, Broberger C (2010) Nucleobindin-2/nesfatin in the endocrine pancreas: distribution and relationship to glycaemic state. J Endocrinol 204(3):255–263
García-Galiano D, Tena-Sempere M (2013) Emerging roles of NUCB2/nesfatin-1 in the metabolic control of reproduction. Curr Pharm Des. In press.
Garcia-Galiano D, Pineda R, Ilhan T et al (2012) Cellular distribution, regulated expression, and functional role of the anorexigenic peptide, NUCB2/nesfatin-1, in the testis. Endocrinology 153(4):1959–1971
Ishida E, Hashimoto K, Shimizu H et al (2012) Nesfatin-1 induces the phosphorylation levels of cAMP response element-binding protein for intracellular signaling in a neural cell line. PLoS One 7(12):e50918
Jiang H, Li LJ, Wang J, Xie JX (2008) Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 212(2):532–537
Kotz CM, Wang C, Teske JA et al (2006) Orexin A mediation of time spent moving in rats: neural mechanisms. Neuroscience 142(1):29–36
Liss B, Bruns R, Roeper J (1999) Alternative sulfonylurea receptor expression defines metabolic sensitivity of K-ATP channels in dopaminergic midbrain neurons. EMBO J 18(4):833–846
Marinelli M, Rudick CN, Hu XT, White FJ (2006) Excitability of dopamine neurons: modulation and physiological consequences. CNS Neurol Disord Drug Targets 5(1):79–97
Merali Z, Cayer C, Kent P, Anisman H (2008) Nesfatin-1 increases anxiety- and fear-related behaviors in the rat. Psychopharmacology (Berl) 201(1):115–123
Mimee A, Smith PM, Ferguson AV (2012) Nesfatin-1 influences the excitability of neurons in the nucleus of the solitary tract and regulates cardiovascular function. Am J Physiol Regul Integr Comp Physiol 302(11):R1297–R1304
Noh J, Chang SY, Wang SY, Chung JM (2011) Dual function of Zn2+ on the intrinsic excitability of dopaminergic neurons in rat substantia nigra. Neuroscience 175:85–92
Oh IS, Shimizu H, Satoh T et al (2006) Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 443:709–712
Ozsavci D, Ersahin M, Sener A et al (2011) The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats. Neurosurgery 68(6):1699–1708, discussion 1708
Price CJ, Hoyda TD, Samson WK, Ferguson AV (2008a) Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J Neuroendocrinol 20(2):245–250
Price CJ, Samson WK, Ferguson AV (2008b) Nesfatin-1 inhibits NPY neurons in the arcuate nucleus. Brain Res 1230:99–106
Prisco S, Natoli S, Bernardi G, Mercuri NB (2002) Group I metabotropic glutamate receptors activate burst firing in rat midbrain dopaminergic neurons. Neuropharmacology 42(3):289–296
Ramanjaneya M, Chen J, Brown JE et al (2010) Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity. Endocrinology 151(7):3169–3180
Shi L, Bian X, Qu Z et al (2013) Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. Nat Commun 4:1435
Stengel A, Tache Y (2010) Nesfatin-1—role as possible new potent regulator of food intake. Regul Pept 163(1–3):18–23
Stengel A, Goebel M, Yakubov I et al (2009) Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 150(1):232–238
Sulzer D (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson’s disease. Trends Neurosci 30(5):244–250
Surmeier DJ, Guzman JN, Sanchez-Padilla J (2010) Calcium, cellular aging, and selective neuronal vulnerability in Parkinson’s disease. Cell Calcium 47(2):175–182
Tang CH, Fu XJ, Xu XL, Wei XJ, Pan HS (2012) The anti-inflammatory and anti-apoptotic effects of nesfatin-1 in the traumatic rat brain. Peptides 36(1):39–45
Vas S, Adori C, Konczol K et al (2013) Nesfatin-1/NUCB2 as a potential new element of sleep regulation in rats. PLoS One 8(4):e59809
Weng Z, Signore AP, Gao Y et al (2007) Leptin protects against 6-hydroxydopamine-induced dopaminergic cell death via mitogen-activated protein kinase signaling. J Biol Chem 282(47):34479–34491
Wienecke M, Werth E, Poryazova R et al (2012) Progressive dopamine and hypocretin deficiencies in Parkinson’s disease: is there an impact on sleep and wakefulness? J Sleep Res 21(6):710–717
Yao LH, Li CH, Yan WW, Huang JN, Liu WX, Xiao P (2011) Cordycepin decreases activity of hippocampal CA1 pyramidal neuron through membrane hyperpolarization. Neurosci Lett 503(3):256–260
Acknowledgments
This study was funded by grants from the 973 Program (2012CB526700, 2011CB504102), National Natural Science Foundation of China (81171207, 31200819), and Ministry of Education of China (20123706120002).
Author information
Authors and Affiliations
Corresponding author
Additional information
Chen Li and Fang Zhang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, C., Zhang, F., Shi, L. et al. Nesfatin-1 Decreases Excitability of Dopaminergic Neurons in the Substantia Nigra. J Mol Neurosci 52, 419–424 (2014). https://doi.org/10.1007/s12031-013-0169-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-013-0169-3